risk of thyroid cancer with semaglutide (Ozempic) carries FDA warnings for C-cell tumors based on rodent studies, emerging human data showing higher thyroid in early users. Over 2,900 lawsuits allege inadequate warnings for Ozempic & thyroid cancer: What

Some patients have also reported appetite suppression and reduced cravings effects that may benefit those struggling with portion control

In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support

The measurable benefits of GLP-1 therapies often outweigh the discomfort caused by side effects

J Am Coll Cardiol 2024;83:843-64

For type 2 diabetes, semaglutide can be an effective medication for regulating blood sugar and eliminate the need for injecting additional insulin